tiprankstipranks
Trending News
More News >
Incyte Corp (INCY)
NASDAQ:INCY

Compare Incyte (INCY) vs. Competitors

Compare
1,901 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Incyte
$101.18
$20.31B
16.97
38.32%
7 Buy
8 Hold
1 Sell
Moderate Buy
BioMarin Pharmaceutical
$56.68
$10.92B
21.24
-10.39%
8 Buy
5 Hold
0 Sell
Moderate Buy
Exelixis
$42.66
$11.73B
17.96
30.86%
5 Buy
7 Hold
1 Sell
Moderate Buy
United Therapeutics
$476.78
$20.53B
17.71
26.01%
5 Buy
3 Hold
0 Sell
Moderate Buy
Ascendis Pharma
$238.80
$14.59B
-52.38
71.95%
13 Buy
0 Hold
0 Sell
Strong Buy
Genmab
$34.40
$21.27B
13.87
68.18%
5 Buy
2 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INCY
Incyte
101.18
27.41
37.16%
BMRN
BioMarin Pharmaceutical
56.68
-7.20
-11.27%
EXEL
Exelixis
42.66
9.73
29.55%
UTHR
United Therapeutics
467.30
115.00
32.64%
ASND
Ascendis Pharma
222.45
95.15
74.74%
GMAB
Genmab
32.93
13.12
66.23%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts